Korea Pharma Co (XKRX:032300) Long-Term Capital Lease Obligation : ₩95 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Korea Pharma Co Long-Term Capital Lease Obligation?

Korea Pharma Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩95 Mil.

Korea Pharma Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (₩283 Mil) to Dec. 2023 (₩197 Mil) and declined from Dec. 2023 (₩197 Mil) to Mar. 2024 (₩95 Mil).

Korea Pharma Co's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (₩117 Mil) to Dec. 2022 (₩727 Mil) but then declined from Dec. 2022 (₩727 Mil) to Dec. 2023 (₩197 Mil).

Korea Pharma Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Korea Pharma Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Pharma Co Long-Term Capital Lease Obligation Chart

Korea Pharma Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

143.75

51.82

116.67

727.27

197.12

Korea Pharma Co Quarterly Data
	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															589.67	439.02	282.67	197.12	95.13

Korea Pharma Co (XKRX:032300) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Korea Pharma Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Korea Pharma Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Korea Pharma Co (XKRX:032300) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Pharma Co Ltd (XKRX:032300) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

8th Floor, 14, Teheran-ro 4-gil, Gangnam-gu, Seoul, KOR

Website

http://www.koreapharma.co.kr

Korea Pharma Co Ltd is a drug manufacturer. The company's products include amino acid drugs; antibiotic drugs; antidotal drugs; antiepileptic drugs; antihistamine drugs; anti-inflammatory drugs; antimicrobial drugs; antiplatelet drugs; circulatory system drugs; cns drugs; dermatological drugs; endocrine drugs; gastrointestinal drugs; hepatic drugs; hormonal drugs; multivitamins; respiratory drugs; skeltal muscle relaxants; specialty drugs; sympathomimetic drugs; and vitamin b1.

Korea Pharma Co (XKRX:032300) Headlines

No Headlines